| Autor: |
Mastrotto F; School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, U.K.; School of Life Sciences, University of Nottingham, Nottingham NG7 2RD, U.K.; Department of Pharmaceutical and Pharmacological Sciences, University of Padova, via F. Marzolo 5, Padova 35131, Italy., Pirazzini M; Department of Biomedical Sciences, University of Padova, Via Ugo Bassi 58/B, Padova 35131, Italy., Negro S; Department of Biomedical Sciences, University of Padova, Via Ugo Bassi 58/B, Padova 35131, Italy., Salama A; Department of Renal Medicine, University College London, London NW3 2PF, U.K., Martinez-Pomares L; School of Life Sciences, University of Nottingham, Nottingham NG7 2RD, U.K., Mantovani G; School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, U.K. |
| Abstrakt: |
The mannose receptor (CD206) is an endocytic receptor expressed by selected innate immune cells and nonvascular endothelium, which plays a critical role in both homeostasis and pathogen recognition. Although its involvement in the development of several diseases and viral infections is well established, molecular tools able to both provide insight on the chemistry of CD206-ligand interactions and, importantly, effectively modulate its activity are currently lacking. Using novel SO 4 -3-Gal-glycopolymers targeting its cysteine-rich lectin ectodomain, this study uncovers and elucidates a previously unknown mechanism of CD206 blockade involving the formation of stable intracellular SO 4 -3-Gal-glycopolymer-CD206 complexes that prevents receptor recycling to the cell membrane. Further, we show that SO 4 -3-Gal glycopolymers inhibit CD206 both in vitro and in vivo, revealing hitherto unknown receptor function and demonstrating their potential as CD206 modulators within future immunotherapies. |
